Foresight Autonomous Holdings Ltd. — FY2020 Form 20-F
Reporting period: Fiscal year ended December 31, 2020. Although the request identifies “2020 Q4,” this filing is an annual report and does not provide standalone fourth-quarter results. Financial statements are prepared under U.S. GAAP and audited by Brightman Almagor Zohar & Co.; the auditor issued an unqualified opinion on the financial statements.
Business context
Foresight is an Israeli development-stage technology company. Its subsidiaries develop QuadSight multispectral vision and related software for obstacle detection, and Eye-Net cellular-based vehicle-to-everything (V2X) collision alerts. The company also holds an investment in rail-safety developer Rail Vision. Foresight said it had not generated significant product revenue and did not expect product-sale revenue for the next few years.
Financial performance and liquidity
| Metric | FY2020 | FY2019 |
|---|---|---|
| Revenue from current products | No significant revenue; no clear consolidated revenue figure provided in the cited discussion | No significant revenue |
| Research and development expense, net | $8.563 million | $10.210 million |
| Marketing and sales expense | $1.268 million | $1.350 million |
| General and administrative expense | $3.005 million | $3.469 million |
| Operating loss | $12.836 million | $15.029 million |
| Equity-method loss from affiliate | $2.718 million | $0.839 million |
| Net loss | $15.375 million | $15.439 million |
| Net cash used in operating activities | $11.495 million | $11.861 million |
- At December 31, 2020, cash and cash equivalents were $38.772 million and short-term deposits were $5.166 million, totaling about $43.938 million. Current assets were $44.381 million; current liabilities were $2.025 million.
- Total assets were $49.923 million, total liabilities $2.878 million, and reported total equity $47.045 million. The balance sheet lists lease liabilities but no conventional borrowings; total lease liabilities were approximately $1.280 million.
- Financing activities provided $45.280 million in 2020, principally from share issuance. The company reported 312.76 million ordinary shares outstanding at year-end, versus 154.65 million a year earlier, reflecting substantial equity issuance and dilution.
- Loss per ordinary share improved to $0.07 from $0.10; loss per ADS was $0.35 versus $0.52. Weighted-average shares increased substantially, affecting per-share comparisons.
Changes, developments and outlook
- Operating loss narrowed 14.6%, mainly as research and development, marketing and sales, and general and administrative expenses declined. Management attributed the R&D reduction in part to short-term expense reductions during the COVID-19 outbreak. Net loss was nearly flat because the equity-method loss increased, largely reflecting Rail Vision.
- During 2020, Foresight reported sales of prototype systems, product-development work, and demonstrations, but these did not amount to significant product revenue. It announced a strategic cooperation agreement with FLIR, joined the AWARD autonomous-heavy-vehicle consortium, and reported an expected approximately $1 million consortium allocation, of which about $0.5 million had been received.
- Management estimated that year-end cash, cash equivalents, and short-term deposits would fund current operations through December 2023. This is an estimate, not a guarantee; the company said additional financing may be required if plans change or commercialization and funding are insufficient.
- Foresight planned to pursue commercial agreements and expand into defense, heavy equipment, and agriculture markets. It also continued commercialization efforts for Eye-Net and a COVID-19 symptom-screening concept. No quantified revenue or profitability guidance was provided.
- In 2021, after year-end, the company sold 1.378 million ADSs under a new at-the-market program for approximately $14 million gross through March 21, 2021. This subsequent financing is not part of FY2020 results.
Risks, contingencies and other notable items
- Foresight has incurred losses since inception, had accumulated losses of about $64.8 million at December 31, 2020, and depends on future commercialization and access to capital. Product development, customer adoption, competition, manufacturing and automotive qualification requirements remain significant execution risks.
- COVID-19 restrictions caused some delays in trials, demonstrations, and installations and could further disrupt personnel, suppliers, customers, or markets. The company reduced short-term expenses and enabled remote work.
- Foresight reported approximately $661,000 of contingent IIA grant obligations at year-end. Royalties of 3%–5% may apply to sales of supported products up to the grant amount, and the grants restrict transfer of funded know-how or manufacturing outside Israel without approval.
- Currency movements, particularly between the Israeli shekel and U.S. dollar, may affect costs and results; the company said it did not hedge foreign-exchange exposure. Its operations are concentrated in Israel and are exposed to regional political, security, and military risks.
- Foresight reported no material legal proceedings and no off-balance-sheet arrangements. It has never paid cash dividends and does not anticipate doing so in the foreseeable future.
- Management concluded disclosure controls and internal control over financial reporting were effective at December 31, 2020. The filing contains no external auditor attestation on internal controls because Foresight relied on the emerging-growth-company exemption.
- Rail Vision’s 2020 financial information included in the filing was unaudited. Foresight lost significant influence over Rail Vision late in 2020 and reclassified its remaining interest; the carrying value was $4.011 million at year-end.
Important facts for investors to verify
- Whether prototype, development, consortium, and other commercial activity converts into recurring, recognized revenue and customer production programs.
- Whether the estimated cash runway through December 2023 remains achievable after operating burn, commercialization costs, and any changes in plans.
- The dilution and terms of 2020 and subsequent equity financings, including the at-the-market program and outstanding share options.
- The status, valuation, and potential liquidity of the Rail Vision investment, including the implications of the shift away from equity-method accounting.
- Progress on product validation, regulatory and quality requirements, IIA approvals or royalties, and the impact of COVID-19 and shekel-dollar movements.